In Brief: Eclipse Surgical Technologies
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical Technologies: Receives FDA approval of an investigational device exemption to commence trials of a minimally invasive approach to transmyocardial laser revascularization as a stand-alone procedure. The cardiac revascularization firm received a separate IDE in January to study use of the TMR procedure as an adjunct to minimally invasive direct coronary bypass surgery ("The Gray Sheet" Jan. 27, p. 15)...